COCP Nilai Total Aset Perusahaan Cocrystal Pharma Inc

Cocrystal Pharma, Inc. (COCP) possesses significant market influence due to its innovative methods for combating viral replication. This price chart illustrates total assets at 6.58, while the company develops treatments for hepatitis and influenza relying on external funding. However, the risk of clinical trial failure and a persistent lack of operating profit create a heavy dependence on new equity issuances.

COCP (Cocrystal Pharma, Inc.) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 29.10.2026

Rincian analitis lan laporan data perusahaan Cocrystal (COCP)

- rega saiki lan proyeksi nilai saham:

Bagan kutipan cocrystalpharma.com|COCP - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Cocrystal Pharma Corp|COCP - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi Saham Cocrystal Pharma|COCP - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku cocrystalpharma.com|COCP - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Cocrystal Pharma, Inc.|COCP - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Cocrystal Pharma Corp|COCP - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Cocrystal Pharma Corp|COCP - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Cocrystal Pharma

Pambiji fundamental:Cocrystal Pharma, Inc.

Produk sing diprodhuksi Cocrystal Pharma, Inc.

A comparative analysis of capital dynamics allows an investor to assess the business resilience of Cocrystal Pharma, Inc. (COCP), where the total value of resources is reverse-engineered through return on assets (ROA) to identify real management efficiency. The absence of in-house manufacturing capacities and the utilization of CDMO contractors optimize the balance sheet structure, which, through an analysis of all company resources, confirms a commitment to minimizing capital expenditures.

Pesaing wigati

Nilai Total Aset Perusahaan GILD (gilead.com)|Aset Agregat Perusahaan cidara.com|Novavax Inc - Nilai Total Aset Perusahaan|Total Aset Perusahaan CVAC|VALN (Valneva Vaccines) - Nilai Agregat Aset|Total Aset Perusahaan VIR (Vir Biotechnology, Inc.)|Total Aset Perusahaan siga.com SIGA|EBS - Aset Agregat Perusahaan|Nilai Agregat Aset AVIR (Atea Pharma)|invivyd.com (IVVD) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Enanta Pharmaceuticals, Inc|INO (Inovio Pharmaceuticals) - Total Aset Perusahaan|Total Aset Perusahaan hillevax.com|Gunggung Aset Perusahaan KLRS (Kalaris Therapeutics)|DYAI (dyadic.com) - Nilai Agregat Aset|NanoViricides - Gunggung Aset Perusahaan|Talphera Corporation - Aset Agregat Perusahaan|Traws Therapeutics - Total Aset Perusahaan|Gunggung Aset Perusahaan Dogwood Therapeutics, Inc. DWTX|Qualigen Therapeutics, Inc. (QLGN) - Aset Agregat Perusahaan|AlloVir - Nilai Agregat Aset|Gunggung Aset Perusahaan VBIV|Total Aset Perusahaan Virios|Aset Agregat Perusahaan Vaxart, Inc. (VXRT)